Equities analysts expect MedEquities Realty Trust Inc (NYSE:MRT) to announce $0.30 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for MedEquities Realty Trust’s earnings. The lowest EPS estimate is $0.29 and the highest is $0.31. MedEquities Realty Trust posted earnings per share of $0.29 during the same quarter last year, which suggests a positive year over year growth rate of 3.4%. The company is scheduled to issue its next earnings results on Tuesday, November 6th.

On average, analysts expect that MedEquities Realty Trust will report full-year earnings of $1.20 per share for the current fiscal year, with EPS estimates ranging from $1.19 to $1.23. For the next year, analysts anticipate that the firm will post earnings of $1.23 per share, with EPS estimates ranging from $1.15 to $1.29. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research analysts that cover MedEquities Realty Trust.

MedEquities Realty Trust (NYSE:MRT) last posted its quarterly earnings results on Wednesday, August 8th. The financial services provider reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.30 by ($0.20). The company had revenue of $17.56 million during the quarter, compared to analysts’ expectations of $17.03 million. MedEquities Realty Trust had a return on equity of 5.73% and a net margin of 30.84%.

Several analysts recently weighed in on the company. Zacks Investment Research downgraded MedEquities Realty Trust from a “buy” rating to a “hold” rating in a research note on Saturday. B. Riley set a $12.00 price target on MedEquities Realty Trust and gave the stock a “buy” rating in a research note on Thursday. Canaccord Genuity cut their price target on MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday. ValuEngine downgraded MedEquities Realty Trust from a “sell” rating to a “strong sell” rating in a research note on Wednesday. Finally, KeyCorp downgraded MedEquities Realty Trust from an “overweight” rating to a “hold” rating and set a $12.00 target price on the stock. in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company. MedEquities Realty Trust presently has an average rating of “Hold” and an average target price of $12.22.

Shares of MedEquities Realty Trust traded down $0.21, hitting $9.96, during midday trading on Tuesday, Marketbeat Ratings reports. The company had a trading volume of 113,788 shares, compared to its average volume of 100,020. The company has a market capitalization of $324.04 million, a P/E ratio of 8.74 and a beta of -0.11. MedEquities Realty Trust has a 52-week low of $9.67 and a 52-week high of $12.05.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 29th. Shareholders of record on Wednesday, August 15th will be paid a dividend of $0.21 per share. The ex-dividend date of this dividend is Tuesday, August 14th. This represents a $0.84 annualized dividend and a yield of 8.43%. MedEquities Realty Trust’s dividend payout ratio is 73.68%.

In other news, Director Bluemountain Capital Managemen sold 19,316 shares of the firm’s stock in a transaction dated Monday, May 14th. The stock was sold at an average price of $10.48, for a total transaction of $202,431.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last quarter, insiders have sold 165,564 shares of company stock worth $1,712,407. Company insiders own 2.50% of the company’s stock.

Institutional investors have recently modified their holdings of the company. Raymond James Financial Services Advisors Inc. grew its stake in shares of MedEquities Realty Trust by 18.8% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 31,018 shares of the financial services provider’s stock valued at $342,000 after buying an additional 4,913 shares during the period. Martingale Asset Management L P boosted its stake in shares of MedEquities Realty Trust by 2.0% in the second quarter. Martingale Asset Management L P now owns 258,242 shares of the financial services provider’s stock valued at $2,846,000 after purchasing an additional 5,100 shares during the period. Schwab Charles Investment Management Inc. boosted its stake in shares of MedEquities Realty Trust by 0.7% in the second quarter. Schwab Charles Investment Management Inc. now owns 764,932 shares of the financial services provider’s stock valued at $8,430,000 after purchasing an additional 5,106 shares during the period. Teachers Insurance & Annuity Association of America boosted its stake in shares of MedEquities Realty Trust by 26.5% in the first quarter. Teachers Insurance & Annuity Association of America now owns 37,703 shares of the financial services provider’s stock valued at $396,000 after purchasing an additional 7,903 shares during the period. Finally, UBS Group AG raised its holdings in MedEquities Realty Trust by 52.3% in the first quarter. UBS Group AG now owns 23,234 shares of the financial services provider’s stock valued at $244,000 after acquiring an additional 7,978 shares in the last quarter. Hedge funds and other institutional investors own 91.65% of the company’s stock.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Read More: Growth Stocks

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.